VCU Massey Cancer Center Minority Based NCI Community Oncology Research Program
VCU Massey Cancer Center Minority Based NCI Community Oncology Research Program
批准号:
8790606
负责人:
HARRY D BEAR
金额:
$100.5万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-08-01 至 2019-07-31
关键词:
Academic Medical CentersAddressAfrican AmericanAwardBehavioralBiological FactorsBudgetsCancer CenterCancer ControlCancer DetectionCancer PatientChildClinicClinical OncologyClinical ResearchClinical TrialsCollaborationsCollectionCommunitiesCommunity Clinical Oncology ProgramComorbidityDataEnrollmentEthnic OriginEvolutionFunding OpportunitiesGoalsGrowthGynecologic OncologyHealth systemHealthcareHematologyHospitalsHuman ResourcesImageIndividualInstitutesInstitutionIntervention StudiesLeadershipLow incomeMalignant NeoplasmsMedical centerMetricMinorityMissionObservational StudyOrganizational PolicyOutcomePatientsPopulationProviderPublic HealthRaceResearchResearch DesignResearch InfrastructureResearch PersonnelResource SharingRoleSiteStructureTreatment outcomeUnderrepresented MinorityUnderserved PopulationUnited States Department of Veterans AffairsUniversitiesVirginiaWashingtonWomanbasecancer carecancer health disparitycancer preventioncancer therapycare deliverycomparative effectivenessdata managementeffectiveness researchexperiencehealth related quality of lifehuman subject protectioninfrastructure developmentinnovationmedically underservedmedically underserved populationmembermultidisciplinarynewsnoveloncologyoperationpatient populationprogramsresearch studysafety netscreeningsocialsuccesstool
中文摘要
描述 3
总体审查标准和影响 3
融资机会公告(FOA)特定标准 7
组织和结构 8
临床试验研究 9
癌症护理交付研究 10
运营/数据管理 12
其他审查标准 14
人类受试者注意事项 14
妇女、少数民族和儿童的融入 14
资源共享 14
预算和支助期 14
特别强调小组名册
描述(由申请人提供):梅西癌症中心(MCC)将作为NCORP少数民族/服务不足社区网站(MB-NCORP)UM-1奖的主要组成部分,与九个合作社区组成部分网站合作。这种伙伴关系的总体目标是将新颖,创新和有效的少数民族招募方法扩展到社区组成站点的扩大基础,增加少数民族和医疗服务不足的个人参与癌症临床试验研究(CCTR)的机会,并将癌症护理交付研究(CCDR)整合到整体MB-NCORP中。因此,本提案的具体目标是:(1)建立一个研究基础设施,
将进一步使社区组成地点能够进行CCTR,重点是与少数族裔和医疗服务不足人群相关的试验,(2)在MCC主要组成地点和整个社区组成地点进行NCI批准的CCTR,以及(3)将癌症护理提供研究(CCDR)纳入总体MB-NCORP。MB-NCORP的研究设计提供了一个完整的癌症研究菜单,包括癌症预防和控制,筛查,治疗,成像和CCDR。拟议的研究与NCI的使命相关,因为MCC和社区组成站点将为低收入、少数民族和医疗服务不足的个人提供癌症临床试验和研究,否则他们将无法获得此类研究。这些研究将从患者、提供者、组织和政策的角度解决许多不同的因素,这些因素导致癌症检测、治疗和结果的已知差异。针对社区中的少数群体/服务不足的人群是缓解这些人群中普遍存在的癌症护理差异的关键一步。
英文摘要
DESCRIPTION 3
OVERALL REVIEW CRITERIA AND IMPACT 3
FUNDING OPPORTUNITY ANNOUNCEMENT (FOA) SPECIFIC CRITERIA 7
ORGANIZATION AND STRUCTURE 8
CLINICAL TRIALS RESEARCH PROGRAM 9
CANCER CARE DELIVERY RESEARCH PROGRAM 10
OPERATIONS/DATA MANAGEMENT 12
ADDITIONAL REVIEW CRITERIA 14
PROTECTIONS FOR HUMAN SUBJECTS 14
INCLUSION OF WOMEN, MINORITIES, AND CHILDREN 14
RESOURCE SHARING PLAN 14
BUDGET AND PERIOD OF SUPPORT 14
SPECIAL EMPHASIS PANEL ROSTER
DESCRIPTION (provided by applicant): Massey Cancer Center (MCC) will serve as the primary component site for an NCORP Minority/Underserved Community Site (MB-NCORP) UM-1 award in partnership with nine collaborating community component sites. The overall objectives of this partnership are to extend novel, innovative, and effective minority recruitment approaches to an expanded base of community component sites, increase opportunities for minority and medically underserved individuals to participate in Cancer Clinical Trial Research (CCTR), and to integrate Cancer Care Delivery Research (CCDR) into the overall MB-NCORP. Accordingly, the specific aims of this proposal are to (1) establish a research infrastructure that
will further enable community component sites to conduct CCTR with an emphasis on trials relevant to minority and medically underserved populations, (2) conduct NCI-approved CCTR at the MCC primary component site and throughout the community component sites, and (3) integrate Cancer Care Delivery Research (CCDR) into the overall MB-NCORP. The research design of the MB-NCORP offers a full menu of cancer studies including those in cancer prevention and control, screening, treatment, imaging, and CCDR. The proposed research is relevant to the mission of the NCI as MCC and the community component sites will bring cancer clinical trials and research to low-income, minority, and medically underserved individuals who otherwise would not have access to such studies. These studies will address many diverse factors from patient, provider, organizational, and policy perspectives that contribute to known disparities in cancer detection, treatment, and outcomes. Targeting the minority/underserved populations in their communities is a critical step toward alleviating the cancer care disparities prevalent in these populations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
VCU Massey Cancer Center Minority/Underserved NCI Community Oncology Research Program
-
批准号:10676243
-
项目类别:
-
资助金额:$107.6万
-
财政年份:2014
-
负责人:HARRY D BEAR
-
依托单位:
VCU Massey Cancer Center Minority/Underserved NCI Community Oncology Research Program
-
批准号:10226979
-
项目类别:
-
资助金额:$116.52万
-
财政年份:2014
-
负责人:HARRY D BEAR
-
依托单位:
VCU Massey Cancer Center Minority/Underserved NCI Community Oncology Research Program
-
批准号:10456776
-
项目类别:
-
资助金额:$118.07万
-
财政年份:2014
-
负责人:HARRY D BEAR
-
依托单位:
CORE--HYBRIDOMA/CELL CULTURE/IMMUNE MONITORING
-
批准号:6592795
-
项目类别:
-
资助金额:$4.12万
-
财政年份:2002
-
负责人:HARRY D BEAR
-
依托单位:
CORE--HYBRIDOMA MONOCLONAL ANTIBODY
-
批准号:6300066
-
项目类别:
-
资助金额:$4.12万
-
财政年份:2000
-
负责人:HARRY D BEAR
-
依托单位:
CORE--HYBRIDOMA MONOCLONAL ANTIBODY AND CELL PRODUCTION
-
批准号:6101741
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1999
-
负责人:HARRY D BEAR
-
依托单位:
CORE--HYBRIDOMA MONOCLONAL ANTIBODY
-
批准号:6217230
-
项目类别:
-
资助金额:$4.12万
-
财政年份:1999
-
负责人:HARRY D BEAR
-
依托单位:
PHASE I STUDY OF ADOPTIVE CELLULAR THERAPY OF SOLID TUMOR MALIGNANCIES
-
批准号:6218472
-
项目类别:
-
资助金额:$0.06万
-
财政年份:1998
-
负责人:HARRY D BEAR
-
依托单位:
PHASE I STUDY OF ADOPTIVE CELLULAR THERAPY OF SOLID TUMOR MALIGNANCIES
-
批准号:6114879
-
项目类别:
-
资助金额:$3.45万
-
财政年份:1998
-
负责人:HARRY D BEAR
-
依托单位:
PHASE I STUDY OF ADOPTIVE CELLULAR THERAPY OF SOLID NEOPLASMS
-
批准号:6246001
-
项目类别:
-
资助金额:$2.76万
-
财政年份:1997
-
负责人:HARRY D BEAR
-
依托单位:
PHASE I STUDY OF ADOPTIVE CELLULAR THERAPY OF SOLID TUMOR MALIGNANCIES
-
批准号:6276114
-
项目类别:
-
资助金额:$3.31万
-
财政年份:1997
-
负责人:HARRY D BEAR
-
依托单位:
PHASE I STUDY--ADOPTIVE CELLULAR THERAPY WITH BRYOSTATIN
-
批准号:2110195
-
项目类别:
-
资助金额:$14.13万
-
财政年份:1995
-
负责人:HARRY D BEAR
-
依托单位:
Early Phase Clinical Research Support
-
批准号:10174768
-
项目类别:
-
资助金额:$2.06万
-
财政年份:1995
-
负责人:HARRY D BEAR
-
依托单位:
PHASE I STUDY--ADOPTIVE CELLULAR THERAPY WITH BRYOSTATIN
-
批准号:2110196
-
项目类别:
-
资助金额:$14.39万
-
财政年份:1995
-
负责人:HARRY D BEAR
-
依托单位:
CORE--HYBRIDOMA MONOCLONAL ANTIBODY
-
批准号:6236279
-
项目类别:
-
资助金额:$8.24万
-
财政年份:1995
-
负责人:HARRY D BEAR
-
依托单位:
CORE--HYBRIDOMA MONOCLONAL ANTIBODY
-
批准号:6268874
-
项目类别:
-
资助金额:$2.06万
-
财政年份:1995
-
负责人:HARRY D BEAR
-
依托单位:
EXPANSION OF ANTITUMOR T CELLS FROM TUMOR-BEARING HOSTS
-
批准号:2894781
-
项目类别:
-
资助金额:$23.95万
-
财政年份:1988
-
负责人:HARRY D BEAR
-
依托单位:
Expansion of Anti Tumor T Cells from Tumor Bearing Hosts
-
批准号:6701284
-
项目类别:
-
资助金额:$26.7万
-
财政年份:1988
-
负责人:HARRY D BEAR
-
依托单位:
EXPANSION OF ANTI-TUMOR T CELLS FROM TUMOR-BEARING HOSTS
-
批准号:3192022
-
项目类别:
-
资助金额:$17.5万
-
财政年份:1988
-
负责人:HARRY D BEAR
-
依托单位:
EXPANSION OF ANTI-TUMOR T CELLS FROM TUMOR-BEARING HOSTS
-
批准号:3192027
-
项目类别:
-
资助金额:$18.94万
-
财政年份:1988
-
负责人:HARRY D BEAR
-
依托单位:
海外基金